Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?

Publisher： Karger

E-ISSN： 1421-9670|45|2|146-148

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.45, Iss.2, 2016-12, pp. : 146-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease Patients

By  

Cardiorenal Medicine, Vol. 6, Iss. 1, 2015-0 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 149-159

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 in Chronic Kidney Disease: Bridging the Gap between Bone Mineral Metabolism and Left Ventricular Hypertrophy

By  

Blood Purification, Vol. 31, Iss. 1-3, 2010-12 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Serum Klotho: Relation to Fibroblast Growth Factor-23 and Other Regulators of Phosphate Metabolism in Children with Chronic Kidney Disease

By  

Nephron, Vol. 129, Iss. 4, 2015-03 ,pp. : 293-299

Karger

Access to resources Recommend Favorite